Webinar: Immunotherapy for Patients with Operable Esophageal and GE Junction Adenocarcinoma
For more than four years, immunotherapy has been available [...]
Possible New Weapon to Fight Esophageal Cancer Magnifies Impact of Radiation on Tumors, Not Healthy Tissue
Late-stage clinical biotechnology company Nanobiotix announced promising first results [...]
Mindy Mintz Mordecai, Founder, President, and CEO of ECAN to Retire
Mindy Mintz Mordecai, Founder, President, and CEO of the [...]
A Message from our Founder & CEO
ECAN has never been a job for me. It’s [...]
Historic Bill Passed by U.S. House of Representatives
In his final official act before Esophageal Cancer cut [...]
A Message from our Founder
“Never doubt that a small group of thoughtful, committed [...]
April is Esophageal Cancer Awareness Month!
ECAN is proud to have started Esophageal Cancer Awareness [...]
Major Insurer Provides Coverage for PreCancer Screening
A First Step for Lucid, perhaps a Giant Leap [...]
Art Journaling for Patients & Caregivers
ECAN is offering Esophageal Cancer Patients & Caregivers [...]
Learn about the Latest Therapy Approved by the FDA for Gastroesophageal Cancer Patients
A new type of therapy has been approved by [...]
Find out about the Latest in Advancements for Esophageal Cancer Treatment
ECAN will host a free webinar on Tuesday, March [...]
FDA approves New Therapy Aimed at a New Target in Esophageal Cancer at the GE Junction
The Food and Drug Administration (FDA) has approved Zolbetuximab [...]